Vitamin D Products

(off-site)

Donate via PayPal

Your tax-deductable gift will help us to be more effective in our mission to end the worldwide epidemic of vitamin D deficiency.

Vitamin D On The Web

See our Vitamin D News page for all the latest vitamin D headlines from around the globe.

Our Best Vitamin D Articles page for links to informative, less-mainstream articles on vitamin D and UV exposure.

Vitamin D Research

back to research menu

Chronic Obstructive Pulmonary Disease (COPD)

Vitamin D and respiratory health. Clin Exp Immunol. 2009 Oct;158(1):20–5. Review
Vitamin D deficiency and chronic lung disease. Can Respir J. 2009 May–Jun;16(3):75–80.
Glucocorticoid resistance in inflammatory diseases. Lancet. 2009 May 30;373(9678):1905–17. Review.
Vitamin D beyond bones in chronic obstructive pulmonary disease: time to act. Am J Respir Crit Care Med. 2009 Apr 15;179(8):630–6. Review.
Chronic obstructive pulmonary disease is associated with osteoporosis and low levels of vitamin D. Osteoporos Int. 2009 Mar 20.
Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2009 Feb 23;169(4):384–90.
Phenotypic differences in alpha 1 antitrypsin-deficient sibling pairs may relate to genetic variation. COPD. 2008 Dec;5(6):353–9.
The significance of Gc-globulin in clinical practice. Postepy Hig Med Dosw (Online). 2008 Nov 7;62:625–31. Review.
Primary and secondary prophylaxis to the use of inhaled glucocorticoid in primary health care. J Asthma. 2008 Aug;45(6):519–22.
The recognition and treatment of vertebral fractures in males with chronic obstructive pulmonary disease. Respir Med. 2008 Aug;102(8):1165–72.
Vitamin D receptor genotypes influence quadriceps strength in chronic obstructive pulmonary disease. Am J Clin Nutr. 2008 Feb;87(2):385–90.
Framingham Heart Study genome-wide association: results for pulmonary function measures. BMC Med Genet. 2007 Sep 19;8 Suppl 1:S8.
The prevalence of osteoporosis in patients with chronic obstructive pulmonary disease: a cross sectional study. Respir Med. 2007 Jan;101(1):177–85.
The role of Gc protein oligosaccharide structure as a risk factor for COPD. Anticancer Res. 2006 Nov–Dec;26(6A):4073–8.
Biological and clinical aspects of the vitamin D binding protein (Gc-globulin) and its polymorphism. Clin Chim Acta. 2006 Oct;372(1–2):33–42. Review.
Genotypes of vitamin-D-binding protein (DBP) in patients with chronic obstructive pulmonary disease and healthy population of Republic Bashkortostan. Mol Biol (Mosk). 2006 Mar–Apr;40(2):231–8.
Genetics of chronic obstructive pulmonary disease, beyond a1-antitrypsin deficiency. Curr Med Chem. 2006;13(24):2857–73. Review.
Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest. 2005 Dec;128(6):3792–8.
Make no bones about it: increasing epidemiologic evidence links vitamin D to pulmonary function and COPD. Chest. 2005 Dec;128(6):3781–3.
Vitamin D deficiency, bone mineral density and weight in patients with advanced pulmonary disease. J Intern Med. 2004 Jul;256(1):56–62.
Therapeutic potential of vitamin D-binding protein. Trends Biotechnol. 2004 Jul;22(7):340–5. Review.
Recognizing and treating glucocorticoid-induced osteoporosis in patients with pulmonary diseases. Chest. 2004 May;125(5):1859–76. Review.
Superiority of alfacalcidol over plain vitamin D in the treatment of glucocorticoid-induced osteoporosis. Rheumatol Int. 2004 Mar;24(2):63–70.
The relationship between vitamin D binding protein gene polymorphism and chronic obstructive pulmonary disease. Zhonghua Nei Ke Za Zhi. 2004 Feb;43(2):117–20.
Risk and severity of COPD is associated with the group-specific component of serum globulin 1F allele. Chest. 2004 Jan;125(1):63–70.
Association of vitamin D binding protein variants with chronic mucus hypersecretion in Iceland. Am J Pharmacogenomics. 2004;4(1):63–8.
Glucocorticoid-induced osteoporosis in patients with sarcoidosis. Am J Med Sci. 2003 Jan;325(1):1–6.
Should COPD patients be routinely evaluated for bone mineral density? J Bone Miner Metab. 2003;21(4):242–6.
Few smokers develop COPD. Why? Respir Med. 2002 Aug;96(8):615–24. Review.
COPD and osteoporosis. Chest. 2002 Feb;121(2):609–20. Review.
Genetic risk factors of chronic obstructive pulmonary disease. Swiss Med Wkly. 2002 Jan 26;132(3–4):27–37. Review.
Association of Gc-globulin variation with susceptibility to COPD and diffuse panbronchiolitis. Eur Respir J. 2001 Nov;18(5):753–7.
Chronic respiratory failure and osteoporosis: a difficult problem to unravel. Rev Mal Respir. 2001 Sep;18(4 Pt 1):361–3.
Susceptibility genes for rapid decline of lung function in the lung health study. Am J Respir Crit Care Med. 2001 Feb;163(2):469–73.
Relationships among diet, physical activity and other lifestyle factors and debilitating diseases in the elderly. Eur J Clin Nutr. 2000 Jun;54 Suppl 3:S143–7 Review.
Use of oral corticosteroids in the United Kingdom. QJM. 2000 Feb;93(2):105–11.
Chronic glucocorticoid therapy-induced osteoporosis in patients with obstructive lung disease. Chest. 1999 Dec;116(6):1733–49. Review.
Genetic risk factors for chronic obstructive pulmonary disease (COPD). Nippon Rinsho. 1999 Sep;57(9):1954–8. Review.
Vitamin D binding protein variants and the risk of COPD. Am J Respir Crit Care Med. 1998 Mar;157(3 Pt 1):957–61.
Genetic risk factors for chronic obstructive pulmonary disease. Eur Respir J. 1997 Jun;10(6):1380–91. Review.
Corticosteroid-induced bone loss. Prevention and management. Drug Saf. 1996 Nov;15(5):347–59. Review.
Osteoporosis in lung transplantation candidates with end-stage pulmonary disease. Am J Med. 1996 Sep;101(3):262–9.
Human monocyte chemotaxis to complement-derived chemotaxins is enhanced by Gc-globulin. J Leukoc Biol. 1994 Mar;55(3):349–54.
Gcglobulin functions as a cochemotaxin in the lower respiratory tract. A potential mechanism for lung neutrophil recruitment in cigarette smokers. Am Rev Respir Dis. 1991 Apr;143(4 Pt 1):844–9.
Inactivation of chemotactic factor inactivator by cigarette smoke. A potential mechanism of modulating neutrophil recruitment to the lung. Am Rev Respir Dis. 1990 Oct;142(4):763–8.
Hypercalcemia in active pulmonary tuberculosis. Ann Intern Med. 1979 Mar;90(3):324–8.

back to research menu

*These statements have not been evaluated by the Food and Drug Administration. These products are not intended to diagnose, treat, cure, or prevent any disease.

Unless otherwise expressly stated, all site content licensed under a Creative Commons License.